Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03306147 · ClinicalTrials.gov registry record · NA
Negating Opioid and Pain Actively Through Intervention
A NA study of Pain and Chronic Pain, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT03306147: Completed NA study of Pain and Chronic Pain, sponsored by Loma Linda University.
NCT03306147 is a NA study of Pain and Chronic Pain that has completed, run by Loma Linda University. The registered enrollment target is 33 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03306147, a NA study of Pain and Chronic Pain, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
Chronic pain is one of the most prevalent and debilitating medical conditions and opioid analgesics are a commonly prescribed class of medications in the United States. Opioid efficacy has been proven in terms of managing acute and chronic pain; however, opioid overdose deaths, addictions, and diversions have all continued to increase over the years. The purpose of this study is to increase patient engagement in pain management and education, and to decrease opioid use by 10% over the study period. This study will also help present opportunities for future studies to obtain insight regarding the chronic use of opioids.
Primary Outcome
Opioid usage will be measured by changes in prescription strength of morphine milligram equivalents
Conditions Studied
Interventions
- BEHAVIORAL Pain education with follow up encounters
Study Locations (1)
California
- Loma Linda University - Loma Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2017-10-12 |
| Est. Completion | 2018-05-17 |
| Phase | NA |
What the finished NCT03306147 record still lists
NCT03306147 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (89% lower).
The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 1 intervention - of which Pain education with follow up encounters is the first listed.
NCT03306147 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03306147 about?
NCT03306147 is a clinical study titled "Negating Opioid and Pain Actively Through Intervention". Chronic pain is one of the most prevalent and debilitating medical conditions and opioid analgesics are a commonly prescribed class of medications in the United States. Opioid efficacy has been proven in terms of managing acute and chronic pain; however, opioid overdose deaths, addictions, and diver...
What is the current status of trial NCT03306147?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2017-10-12. Estimated completion is 2018-05-17.
What conditions does trial NCT03306147 study?
This clinical trial studies the following conditions: Pain, Chronic Pain, Opioid Use.
What interventions are being tested in trial NCT03306147?
The interventions under investigation include: Pain education with follow up encounters (BEHAVIORAL).
Who is sponsoring clinical trial NCT03306147?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03306147 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03306147's enrollment target sits among peer trials
33 304th of 374 higher than 69 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Postoperative Pain After Activation of Irrigant
RECRUITING · NA
-
Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)
RECRUITING · NA
-
Pain With Dementia
RECRUITING · NA
-
Oklahoma Study of Native American Pain Risk IV: Smoking Cessation and Pain
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI